ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,450,106 | -10.3% | 1,343,040 | +1.6% | 1.01% | -6.1% |
| Q2 2023 | $40,639,510 | -14.2% | 1,322,040 | +0.5% | 1.08% | -18.4% |
| Q1 2023 | $47,391,700 | -10.8% | 1,315,340 | -2.1% | 1.32% | -6.8% |
| Q4 2022 | $53,109,911 | -1.6% | 1,343,740 | +0.0% | 1.42% | -13.2% |
| Q3 2022 | $53,975,000 | -4.7% | 1,343,340 | -0.2% | 1.63% | +2.0% |
| Q2 2022 | $56,609,000 | +7.9% | 1,346,540 | 0.0% | 1.60% | +24.7% |
| Q1 2022 | $52,461,000 | -3.7% | 1,346,540 | -1.5% | 1.28% | +2.4% |
| Q4 2021 | $54,496,000 | +30.2% | 1,367,540 | +18.1% | 1.25% | +23.2% |
| Q3 2021 | $41,844,000 | +41.7% | 1,157,840 | +60.8% | 1.02% | +49.3% |
| Q2 2021 | $29,523,000 | – | 720,240 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |